Multiple Implantable Cardioverter-Defibrillator Shocks in Ischemic Cardiomyopathy Compels Coronary Vascularization Reassessment

1 Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS). Circulation. 2000;101:1297–1302. doi: 10.1161/01.cir.101.11.1297. Search in Google Scholar

2 Moss AJ. MADIT-II and its implications. Eur Heart J. 2003;24:16–18. doi: 10.1016/s0195-668x(02)00627-9. Search in Google Scholar

3 Sears SF, Rosman L, Sasaki S, et al. Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial. Heart Rhythm. 2018;15:734–740. doi: 10.1016/j.hrthm.2017.12.026. Search in Google Scholar

4 Braunschweig F, Boriani G, Bauer A, et al. Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management. EP Europace. 2010;12:1673–1690. doi: 10.1093/europace/euq316. Search in Google Scholar

5 Jackson KP. ICD follow-up and troubleshooting. In: K. Ellenbogen, K. Kaszala ed. Cardiac Pacing and ICDs 7th Ed. Philadelphia, John Wiley & Sons Ltd., 2020: 395–415. Search in Google Scholar

6 Lee JA-O, Lee SA-O, Choi EA-O, et al. Temporal Trends of Cardiac Implantable Electronic Device Implantations: a Nationwide Population-based Study. Korean Circ J. 2019;49:841–852. doi: 10.4070/kcj.2018.0444 Search in Google Scholar

7 Hofer DA-O, Steffel J, Hürlimann D, et al. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice – an underestimated complication? J Interv Card Electrophysiol. 2017;50:219–226. doi: 10.1007/s10840-017-0297-8. Search in Google Scholar

8 Proclemer A, Ghidina M, Gregori D, et al. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005–07. EP Europace. 2009;11:465–475. doi: 10.1093/europace/eun370. Search in Google Scholar

9 Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2022;43:3997–4126. doi: 10.1093/eurheartj/ehac262. Search in Google Scholar

10 Kalarus Z, Svendsen JH, Capodanno D, et al. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). EP Europace. 2019;21:1603–1604. doi: 10.1093/europace/euz163. Search in Google Scholar

11 Rao S. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review. Adv Ther. 2022;39:845–861. doi: 10.1007/s12325-021-01989-z. Search in Google Scholar

12 McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2023;44:3627–3639. doi: 10.1093/eurheartj/ehad195. Search in Google Scholar

13 Visseren FF, Mach F, Mach FF, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022;29:5–115. doi: 10.1093/eurheartj/ehab484. Search in Google Scholar

14 Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12:e69–100. doi: 10.1016/j.hrthm.2015.05.008. Search in Google Scholar

15 Varma N, Epstein EA, Irimpen A, Schweikert R, Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325–332. doi: 10.1161/CIRCULATIONAHA.110.937409. Search in Google Scholar

16 Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011;57:1181–1189. doi: 10.1016/j.jacc.2010.12.012. Search in Google Scholar